AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation.
AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK – two companies with similar science-based cultures and a shared vision of the pharmaceutical industry.
The merger aimed to improve the combined companies’ ability to deliver long term growth and enduring shareholder value through:
Our commitment to making a meaningful difference to patient health is founded on innovative science.
AstraZeneca’s mission is to create a meaningful difference in the lives of the patients we serve and the people who work here.
https://www.astrazeneca.co.uk/medicines-AZ.html
https://www.companieshistory.com/astrazeneca
https://www.comparably.com/companies/astrazeneca-plc/mission
https://en.wikipedia.org/wiki/AstraZeneca
https://pharmaphorum.com/views-analysis-sales-marketing/a_history_of-_astrazeneca/